Follow the Eris Lifesciences Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Eris Lifesciences Limited has recorded 44 public disclosures. Market capitalisation: €190.6bn. The latest transaction was disclosed on 18 August 2023 (Sale). Among the most active insiders: Himanshu Jayantbhai Shah. Every trade is free.
44
Insider Decl.
n/a
Thresholds
€7m
18 ops.
Buy Volume
€9m
26 ops.
Sell Volume
10Σ signal
Buys €7m€9m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,250 of 28,958 companies
58.8
score / 100
Value
42
Quality
76
FCF yld1.3%
Earn yld3.3%
EV/EBITDA19.3x
ROE18%
Gross mgn74%
Net mgn20%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
26,175 shares@ ₹725.42310.0001% mcap42.9% of flowEquity SharesSEBI:cf254e4dadb6bdda823fdb6b14024e1dc3c9fc44
25 of 44 declarations
About Eris Lifesciences Limited
Eris Lifesciences Limited is a company focused on the healthcare and pharmaceutical sector, providing a range of pharmaceutical products. It is listed on the XBOM market.